Hepatocellular carcinoma (HCC) is widespread cancer with a high degree of morbidity and
mortality in individuals worldwide and a serious concern for its resistance to present …

In this study a novel pH-responsive magnetic nanocomposite based on reduced graphene
oxide was developed for combination of doxorubicin (Dox)-cisplatin (Cis) delivery to destroy …

Liver cancer is listed as the fifth-ranked cancer, responsible for 9.1% of all cancer deaths
globally due to its assertive nature and poor survival rate. To overcome this obstacle, efforts …

Integrating different therapies into a single nanoplatform has shown great potential for
synergistic anti-tumor therapy. In this work, we fabricated the graphene oxide (GO)-based …

Due to their high specific surface area, graphene oxide and graphene oxide-base
nanoparticles have great potential both in dual-drug delivery and combination …

Hepatocellular carcinoma or hepatoma is a primary malignant neoplasm that responsible for
75–90% of all liver cancer in humans. Nanotechnology introduced the dual drug …

Because of its unique chemical and physical properties, graphene oxide (GO) has attracted
a large number of researchers to explore its biomedical applications in the past few years …

This paper describes the development of mitoxantrone-loaded PEGylated graphene
oxide/magnetite nanoparticles (PEG-GO/Fe3O4-MTX), and investigation of its preliminary …

Multi-modal strategies may enhance anticancer efficacy by overcoming tumor drug
resistance due to different anticancer pathways and mechanisms. Herein, a novel method of …

As an inorganic nanomaterial, graphene nanocomposites have gained much attention in
cancer nanotechnology compared with the other inorganic nanomaterial in recent times …